Evidence map›Paper›PMID 31823665›Full record

ArticleInquiry : a journal of medical care organization, provision and financing

Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.

Saval Khanal, Lennert Veerman, Margaret Ewen, Lisa Nissen, Samantha Hollingworth

Open access · goldAbstract read
In one paragraph

Article in Inquiry : a journal of medical care organization, provision and financing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Saval KhanalNepal Health Research and Innovation Foundation, Lalitpur, Nepal.ORCID 0000-0001-5201-0612
Lennert VeermanSchool fo Medicine, Griffith University, Southport, Australia.
Margaret EwenHealth Action International, Amsterdam, The Netherlands.
Lisa NissenSchool of Clinical Sciences, Queensland University of Technology, Brisbane, Australia.
Samantha HollingworthSchool of Pharmacy, The University of Queensland, Brisbane, Australia.
The University of Queensland · AUGriffith University · AUHealth Action International · NLQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the availability, price, and affordability of essential noncommunicable disease (NCD) medicines in Nepal. A cross-sectional survey was conducted in Nepal in 2015 using World Health Organization/Health Action International (WHO/HAI) methodology. We collected data on the availability and price of 60 essential NCD medicines from medicine distribution outlets in both the public and private health care sectors in 6 regions. Essential NCD medicines were more available in the private sector (78%) than the public sector (60%). Furosemide tablets were the cheapest (NPR 0.6/10 tablets) and streptokinase injections were the most expensive (NPR 2200/vial) drugs. There was no significant difference (

Indexed as

Cross-Sectional StudiesDrugs, EssentialFees, PharmaceuticalHealth Services AccessibilityHumansNepalNoncommunicable DiseasesPharmaceutical PreparationsPrivate SectorPublic SectorDrugs, EssentialPharmaceutical Preparationsaccess to medicinesessential medicineslow- and middle-income countries (LMICs)Nepalnoncommunicable diseases

Identifiers

PMID31823665
PMCPMC6906349
OpenAlexW2994833880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.